7th International Conference on


Theme: Raising awarness and advancement towards Hepatitis and Liver Diseases.

Event Date & Time

Event Location

London, UK

16 years of lifescience communication

Performers / Professionals From Around The Globe

Tracks & Key Topics

Hepatitis 2019

Hepatitis-2019 Info

We are honoured to invite you to the 7th International Conference on Hepatitis and Liver Diseases (Hepatitis 2019) to be held in London, UK during May 02-04, 2019. The conference highlights the theme “Raising awareness and advancement towards Hepatitis and Liver Diseases”.

The conference invites Hepatologists, Gastroenterologists, Virologists, Microbiologists, Pathologists, Oncologists, Toxicologists, Researchers, Students, Young researchers and business delegates across the World.

Hepatitis 2019 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease.

Conference Highlights



Why to attend Hepatitis-2019

The main reason about Hepatitis and Liver Diseases meeting is to discuss about various new approaching technologies, future and current developments and Features of analysis determining the Future of Hepatitis and Liver Diseases. Experts from all over world will discuss the pros and cons of all the developments and how the approaching technologies or procedures can change the face of Hepatology, Hepatologists, Gastroenterologist and Hepatitis and Liver Diseases Lecturers. Also, it is a platform, where everyone can share their ideas and interact with global experts to expand their knowledge in the arena of Hepatitis and Liver Diseases and to build new contacts creating collaborative research opportunities in the sector of Hepatology and related disciplines.

Here are the quick insights of the upcoming Hepatitis Conference 2019 at London, UK

  • Meet the Hepatologist and Gastroenterologist from 20+ countries around the globe
  • Earn up to 21 CME/ CPD credits
  • Meet your peers and evaluate your research in front of experts
  • World-class platform to exhibit your products and services
  • Special Workshop/ Symposiums, B2B and interactive sessions with industry Sponsors and Exhibitors
  • More than 25 presentations from Industry and Academia leaders
  • One- on -one interaction, B2B, and B2A etc.
  • Well organizing program with 5+ hours of networking sessions
  • Interactive panel discussions and Q&A sessions
  • Lively Exhibition area filled with the leading industry solution providers


Scientific Sessions

Track 1: Hepatitis B

 Hepatitis B is an infectious disease which causes inflammation in the liver. Hepatitis B is caused by Hepatitis virus (HBV). For some of the people, Hepatitis B became chronic; it means the symptoms last more than 6 months. Due to long lasting symptoms of this virus it may causes risk to the liver and causes certain disease like liver damage i.e liver cancer or liver cirrhosis which causes permanent scar of the liver. Most of the adult those who are suffering from Hepatitis B virus get cured even they have sign and symptoms in severe. But infant and children those who are suffering from HBV have more likely to develop a Chronic Hepatitis B infection. HBV can survive outside at least for 7days still the virus have the ability to cause the infection. A vaccine can prevent from hepatitis infection.

But there is no such cure for the person those who already in the condition. If you are infected then you can only prevent by taking certain precautions for the spreading the virus to the others.

Pathogenesis and clinical manifestation of Hepatitis B is due to interaction of HBV and host immune system, which leads to liver damage, liver cancer or liver cirrhosis and hepatocellular carcinoma .
Track 2: Hepatitis A,D&E

Now a days hepatitis A is a commonly causing viral disease which causes inflammation in the liver. It is caused by hepatitis A virus. It is a short term disease that will not develop to the chronic disorder. This virus is transmitted from one person to another through faecal-oral infection (food or drinks that has been contaminated with stool of a person who already affected by this virus) . HAV commonly spread in those areas where poor sanitary conditions or where good personal cleanliness is not observed well.

Hepatitis D

 It is additionally referred to as delta virusHDV(Hepatitis D virus) is an RNA virus it needs hepatitis B virus to replicate. HDV causes illness only in those patients who have the hepatitis B virus. Transmission happens through infected blood, needles, or sexual contact from an infected person. HDV infection can be prevented by the hepatitis B vaccine and avoiding those activities that results in attain this virus. Those that don’t seem to be vaccinated to HBV square measure in danger of obtaining this viral disease that result in cause hepatitis D.

Hepatitis E

Hepatitis E is an infectious disease which causes inflammation in the liver. It is caused by hepatitis E virus. According to resent survey 20 million cases of hepatitis E infection are been registered. and 44,000 of these cases resulted in death. It is more common in developing countries. Hepatitis E usually resolves by itself, but may develop into acute liver failure.


Hepatitis Conferences | Hepatitis A,D&E Conferences | Hepatology Conferences | CME Hepatitis Events | Hepatitis B Meeting | Hepatitis Workshop | Hepatitis Meetings | CME Hepatitis Conferences | Hepatitis Congress | Hepatitis  Expo | Hepatitis Meet | Hepatitis  Events

Track 3: Hepatitis C

Hepatitis C is the viral infectious disease which causes inflammation in the liver. It can be either acute or chronic. Hepatitis C caused by the Hepatitis C virus (HCV). HCV can be transferred by exposure to infected blood, intravenous drug abuse with the use of contaminated. Some people who experience the hepatitis C virus for short time (up to six months) and then they get better on their own.  This is called acute Hepatitis C.  But most of the people (around 75% – 85%) will go on to develop chronic (long-term) Hepatitis C, it means doesn’t go away. Worldwide, viral hepatitis kills more than one million people each year, and more than 350 million people are chronically infected with Hepatitis C. Hepatitis C virus doesn’t show any symptoms or very mild symptoms in the early stage. Many people don’t have an idea that they are suffering from hepatitis c virus until liver damage show up. Sometimes they get to know by routine medical testing. The recent significant advancements in treating hepatitis C build-up the improvements over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and upcoming treatments, can be potentially cured.


Hepatitis Conferences | Hepatitis C Conferences | Hepatology Conferences | CME Events | Hepatitis B Meeting | Hepatitis Workshop | Hepatitis Meetings | CME Hepatitis Conferences | Hepatitis Congress | Hepatitis C Expo | Hepatitis Meet | Hepatitis  Events

 Hepatocellular carcinoma is that the primary distortion for the foremost liver cancers. This kind of carcinoma occurs in principally in men as compare to women and typically seen in individuals age fifty and higher. It is commonly related with liver cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, wherever the endemic high prevalence of Hepatitis B and Hepatitis C strongly predisposes to the event of chronic disease and subsequent development of Hepatocellular carcinoma(HCC). Other risk factors can include a history of alcohol abuse. Hepatocellular carcinoma is that the third leading reason for cancer deaths worldwide, with manifested 16–32 times higher in developing countries than in developed countries. Several studies have incontestable that 10%-25% of  HCC develops in those person who already suffered with chronic Hepatitis B. Hepatitis B carriers have the life time risk of getting Hepatocellular carcinoma sickness.

Co-infection includes instantaneous infection of a single cell by two or additional virus particles (when an individual gets infected with two different strains of HIV at once. Super-infection is when a person gets infected by one strain of HIV and after time gets infected with a second and different strain of HIV. Experts estimate that concerning forty per cent of patients with HIV area unit co-infected with viral hepatitis.

HCV is transmitted some of the same way as HIV and viral hepatitis. HIV not only increases the risk of  liver damage but it also speed up the liver cancer which may leads to cause damage faster.



Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!


A huge thanks to all our amazing partners. We couldn’t have a conference without you!